Company Directory / research

Variant Bio logo

PrivateFor profitresearchSeattle, United States

Variant Bio

Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.

Founded
2018
8 years ago
Staff
11-50
band, as listed
Followers
-
on LinkedIn
Funding
$130M
as listed, currency not stated

Set against six million companies

Size

1-1011-5051-100101-250251-500501-10001k-5k5k-10k10k+

11-50 people: larger than 33% of companies with a size listed

Age

201819002026

8 years old.

Reach

Website ranked #2,783,369 in the world for traffic, about 6k visits a month.

What it does

BiotechnologyGeneticsMedicalTherapeutics

Funding, as listed

$130M currency not stated

  • Rounds2
  • LatestSeries b, Nov 2021
  • Investors8, 2 leading

What the source datasets report. We have not watched these rounds ourselves.

FoundersKaja Wasik, Kaja Wasik, Stephane Castel

Every detail we hold

Everything the source datasets list about Variant Bio, field by field. Contact details are held but never shown.

The company

Name
Variant Bio
Type
For profit
Status
Private
Founded
2018
Founders
Kaja Wasik, Kaja Wasik, Stephane Castel
Industry
research
Categories
Biotechnology, Genetics, Medical, Therapeutics

Where

City
Seattle
Country
United States
Markets
Greater Seattle Area, West Coast, Western US

Size and reach

Staff band
11-50
Web traffic rank
#2,783,369
Monthly web visits
6,154

Funding, as listed

Total
129,700,000 (currency not stated)
Rounds
2
Latest round
Series b
Latest round date
Nov 2021
Investors
8
Lead investors
2
Listing status
private

About this record

Sources
Crunchbase
Last imported
Sept 2026

Growth, as the source summarises it

Variant Bio may be growing as evidenced by its partnership with Evotec to develop fibrosis treatments. This collaboration indicates an expansion of Variant Bio's research and development capabilities, which is a positive indicator of growth in the biotechnology and therapeutics industry. The partnership with a notable company like Evotec suggests that Variant Bio is increasing its operational scope and potentially its market presence, which are both indicative of a company in a growth phase.

Summaries written by the source dataset, not by us, and not checked.

Companies like it

research in United States.

See all in the directory →

From the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.